Imtiaz S, Nigatu YT, Ali F, Douglas L, Hamilton HA, Rehm J, et al. Cannabis legalization and cannabis use, daily cannabis use and cannabis-related problems among adults in Ontario, Canada (2001–2019). Drug Alcohol Depend. 2023;244:109765. https://doi.org/10.1016/j.drugalcdep.2023.109765.

Article  PubMed  Google Scholar 

Kilmer JR, Rhew IC, Guttmannova K, Fleming CB, Hultgren BA, Gilson MS, et al. Cannabis Use among Young adults in Washington State after legalization of nonmedical Cannabis. Am J Public Health. 2022;112(4):638–45. https://doi.org/10.2105/ajph.2021.306641.

Article  PubMed  PubMed Central  Google Scholar 

Hasin DS, Saxon AJ, Malte C, Olfson M, Keyes KM, Gradus JL, et al. Trends in Cannabis Use Disorder diagnoses in the U.S. Veterans Health Administration, 2005–2019. Am J Psychiatry. 2022;179(10):748–57. https://doi.org/10.1176/appi.ajp.22010034.

Article  PubMed  PubMed Central  Google Scholar 

Hammond D, Goodman S, Wadsworth E, Freeman TP, Kilmer B, Schauer G, et al. Trends in the use of cannabis products in Canada and the USA, 2018–2020: findings from the International Cannabis Policy Study. Int J Drug Policy. 2022;105:103716. https://doi.org/10.1016/j.drugpo.2022.103716.

Article  PubMed  Google Scholar 

Chiu V, Leung J, Hall W, Stjepanović D, Degenhardt L. Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA. Neuropharmacology. 2021;193:108610. https://doi.org/10.1016/j.neuropharm.2021.108610.

Article  CAS  PubMed  Google Scholar 

Hall W, Lynskey M. Assessing the public health impacts of legalizing recreational cannabis use: the US experience. World Psychiatry. 2020;19(2):179–86. https://doi.org/10.1002/wps.20735.

Article  PubMed  PubMed Central  Google Scholar 

Weinberger AH, Wyka K, Goodwin RD. Impact of cannabis legalization in the United States on trends in cannabis use and daily cannabis use among individuals who smoke cigarettes. Drug Alcohol Depend. 2022;238:109563. https://doi.org/10.1016/j.drugalcdep.2022.109563.

Article  PubMed  Google Scholar 

Rhee TG, Rosenheck RA. Increasing Use of Cannabis for Medical purposes among U.S., residents, 2013–2020. Am J Prev Med. 2023;65(3):528–33. https://doi.org/10.1016/j.amepre.2023.03.005.

Article  PubMed  PubMed Central  Google Scholar 

Costiniuk CT, Saneei Z, Routy JP, Margolese S, Mandarino E, Singer J, et al. Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028-study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation. BMJ Open. 2019;9(1):e024793. https://doi.org/10.1136/bmjopen-2018-024793.

Article  PubMed  PubMed Central  Google Scholar 

Zevin AS, McKinnon L, Burgener A, Klatt NR. Microbial translocation and microbiome dysbiosis in HIV-associated immune activation. Curr Opin HIV AIDS. 2016;11(2):182–90. https://doi.org/10.1097/coh.0000000000000234.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klatt NR, Chomont N, Douek DC, Deeks SG. Immune activation and HIV persistence: implications for curative approaches to HIV infection. Immunol Rev. 2013;254(1):326–42. https://doi.org/10.1111/imr.12065.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klatt NR, Funderburg NT, Brenchley JM. Microbial translocation, immune activation, and HIV disease. Trends Microbiol. 2013;21(1):6–13. https://doi.org/10.1016/j.tim.2012.09.001.

Article  CAS  PubMed  Google Scholar 

Pinto-Cardoso S, Klatt NR, Reyes-Terán G. Impact of antiretroviral drugs on the microbiome: unknown answers to important questions. Curr Opin HIV AIDS. 2018;13(1):53–60. https://doi.org/10.1097/coh.0000000000000428.

Article  CAS  PubMed  Google Scholar 

Sajdeya R, Brown JD, Goodin AJ. Perinatal Cannabis exposures and Autism Spectrum disorders. Med Cannabis Cannabinoids. 2021;4(1):67–71. https://doi.org/10.1159/000515871.

Article  PubMed  PubMed Central  Google Scholar 

Bruce D, Bouris AM, Bowers S, Blocker O, Lee SY, Glidden MF, et al. Medical, therapeutic, and recreational use of cannabis among young men who have sex with men living with HIV. Addict Res Theory. 2020;28(3):250–9. https://doi.org/10.1080/16066359.2019.1629427.

Article  PubMed  Google Scholar 

Dʼsouza G, Matson PA, Grady CD, Nahvi S, Merenstein D, Weber KM, et al. Medicinal and recreational marijuana use among HIV-infected women in the women’s interagency HIV Study (WIHS) cohort, 1994–2010. J Acquir Immune Defic Syndr. 2012;61(5):618–26. https://doi.org/10.1097/QAI.0b013e318273ab3a.

Article  PubMed  PubMed Central  Google Scholar 

Haney M, Gunderson EW, Rabkin J, Hart CL, Vosburg SK, Comer SD, et al. Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep. J Acquir Immune Defic Syndr. 2007;45(5):545–54. https://doi.org/10.1097/QAI.0b013e31811ed205.

Article  CAS  PubMed  Google Scholar 

Chayama KL, Valleriani J, Ng C, Haines-Saah R, Capler R, Milloy M-J, et al. The role of cannabis in pain management among people living with HIV who use drugs: a qualitative study. Drug Alcohol Rev. 2021;40(7):1325–33. https://doi.org/10.1111/dar.13294.

Article  PubMed  PubMed Central  Google Scholar 

Ellis RJ, Peterson SN, Li Y, Schrier R, Iudicello J, Letendre S, et al. Recent cannabis use in HIV is associated with reduced inflammatory markers in CSF and blood. Neurol Neuroimmunol Neuroinflammation. 2020;7(5):e809. https://doi.org/10.1212/NXI.0000000000000809.

Article  Google Scholar 

Costiniuk CT, Jenabian M-A. Cannabinoids and inflammation: implications for people living with HIV. AIDS. 2019;33(15):2273–88. https://doi.org/10.1097/qad.0000000000002345.

Article  CAS  PubMed  Google Scholar 

Fogarty A, Rawstorne P, Prestage G, Crawford J, Grierson J, Kippax S. Marijuana as therapy for people living with HIV/AIDS: social and health aspects. AIDS Care. 2007;19(2):295–301. https://doi.org/10.1080/09540120600841930.

Article  CAS  PubMed  Google Scholar 

Joint United Nations Programme on HIV/AIDS (UNAIDS). Global HIV statistics 2024 fact sheet. December 2023.

Weichseldorfer M, Affram Y, Heredia A, Rikhtegaran-Tehrani Z, Sajadi MM, Williams SP, et al. Combined cART including Tenofovir Disoproxil, Emtricitabine, and Dolutegravir has potent therapeutic effects in HIV-1 infected humanized mice. J Transl Med. 2021;19(1):453. https://doi.org/10.1186/s12967-021-03120-w.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shin YH, Park CM, Yoon CH. An overview of human immunodeficiency Virus-1 antiretroviral drugs: General principles and current status. Infect Chemother. 2021;53(1):29–45. https://doi.org/10.3947/ic.2020.0100.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Menéndez-Arias L, Delgado R. Update and latest advances in antiretroviral therapy. Trends Pharmacol Sci. 2022;43(1):16–29. https://doi.org/10.1016/j.tips.2021.10.004.

Article  CAS  PubMed  Google Scholar 

Kemnic TR, Gulick PG. HIV antiretroviral therapy. StatPearls Publishing, Treasure Island (FL); 2023.

Ghosh AK. Four decades of continuing innovations in the development of antiretroviral therapy for HIV/AIDS: Progress to date and future challenges. Global Health Med. 2023;5(4):194–8. https://doi.org/10.35772/ghm.2023.01013.

Article  Google Scholar 

Bale MJ, Kearney MF, Review. HIV-1 phylogeny during suppressive antiretroviral therapy. Curr Opin HIV AIDS. 2019;14(3):188–93. https://doi.org/10.1097/coh.0000000000000535.

Balcom EF, Roda WC, Cohen EA, Li MY, Power C. HIV-1 persistence in the central nervous system: viral and host determinants during antiretroviral therapy. Curr Opin Virol. 2019;38:54–62. https://doi.org/10.1016/j.coviro.2019.06.004.

Article  CAS  PubMed  Google Scholar 

Vidot DC, Lerner B, Gonzalez R, Cannabis, Use. Medication Management and Adherence among persons living with HIV. AIDS Behav. 2017;21(7):2005–13. https://doi.org/10.1007/s10461-017-1782-x.

Bonn-Miller MO, Oser ML, Bucossi MM, Trafton JA. Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms. J Behav Med. 2014;37(1):1–10. https://doi.org/10.1007/s10865-012-9458-5.

Article  PubMed